Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

OSE Immunotherapeutics collaborates with Microsoft to further develop its digital infrastructures

OSE Immunotherapeutics SA today announces that the Company is one of the first biotech startup companies selected by Microsoft France to be a privileged...

Moderna invests 500 million euros in Spain to boost vaccine production

Moderna plans to invest around 500 million euros ($520.60 million) in a new laboratory in Spain to boost its production of vaccines, Spanish Prime...

Rune Labs gets FDA approval to use Apple Watch to track Parkinson’s disease symptoms

San Francisco-based startup Rune Labs on Monday said it received clearance from the U.S. Food and Drug Administration to use the Apple Watch to...

Valneva stocks fall as European deal on COVID vaccine flounders

Valneva shed around a quarter of its market value on Monday after the French drugmaker warned that the future of its COVID-19 vaccine was...

FDA approves Lilly and Incyte’s Olumiant® for alopecia areata

Eli Lilly and Company and Incyte announced  that the U.S. Food and Drug Administration (FDA) has approved OLUMIANT® (baricitinib), a once-daily pill, as a...

Cogent Biosciences begins $125 million public offering

Cogent Biosciences, Inc., a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten public...
spot_img

Expert Articles

spot_img